Lung Cancer: An Evidence-Based Approach to Multidisciplinary Management
Editat de Erin Alexis Gillaspie, Leora Horn, Amanda S. Cassen Limba Engleză Hardback – 11 oct 2023
Preț: 1041.30 lei
Preț vechi: 1394.13 lei
-25% Nou
Puncte Express: 1562
Preț estimativ în valută:
199.43€ • 205.47$ • 167.06£
199.43€ • 205.47$ • 167.06£
Carte disponibilă
Livrare economică 27 ianuarie-10 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323695732
ISBN-10: 0323695736
Pagini: 352
Dimensiuni: 152 x 229 mm
Greutate: 0.45 kg
Editura: Elsevier
ISBN-10: 0323695736
Pagini: 352
Dimensiuni: 152 x 229 mm
Greutate: 0.45 kg
Editura: Elsevier
Cuprins
1 Lung Cancer Screening and Prevention
2 Lung Cancer: Diagnostic Techniques
3 Histology and Molecular Testing
4 Surgical Considerations in Lung Cancer Treatment
5 Surgically Resectable Disease
6 Oligometastatic Disease
7 Locally Advanced Non-Small Cell Lung Cancer
8 First-Line Therapy
9 Second-Line Therapy in Advanced Non-Small Cell Lung Cancer
10 Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Clinical Approach
11 Diagnosis and Treatment of Anaplastic Lymphoma Kinase (ALK)Rearranged Non2Small Cell Lung Cancer
12 Other Molecular Cohorts Including ROS1, BRAF, HER2, MET, NTRK, RET, KRAS
13 Immunotherapy
14 Small Cell Lung Cancer
Index
2 Lung Cancer: Diagnostic Techniques
3 Histology and Molecular Testing
4 Surgical Considerations in Lung Cancer Treatment
5 Surgically Resectable Disease
6 Oligometastatic Disease
7 Locally Advanced Non-Small Cell Lung Cancer
8 First-Line Therapy
9 Second-Line Therapy in Advanced Non-Small Cell Lung Cancer
10 Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Clinical Approach
11 Diagnosis and Treatment of Anaplastic Lymphoma Kinase (ALK)Rearranged Non2Small Cell Lung Cancer
12 Other Molecular Cohorts Including ROS1, BRAF, HER2, MET, NTRK, RET, KRAS
13 Immunotherapy
14 Small Cell Lung Cancer
Index